- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Haydon, D. T.
- Articles by Samuel, A. R.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Haydon, D. T.
- Articles by Samuel, A. R.
Evidence for Positive Selection in Foot-and-Mouth Disease Virus Capsid Genes From Field Isolates
Daniel T. Haydona, Armanda D. Bastosb, Nick J. Knowlesc, and Alan R. Samuelca Centre for Tropical Veterinary Medicine, University of Edinburgh, Roslin, Midlothian, EH25 9RG Scotland,
b Exotic Diseases Division, Onderstepoort Veterinary Institute, Onderstepoort 0110, South Africa
c Institute for Animal Health, Pirbright Laboratory, Woking GU24 0NF, England
Corresponding author: Daniel T. Haydon, University of Edinburgh, Easter Bush, Roslin, Midlothian EH25 9RG, Scotland., daniel.haydon{at}ed.ac.uk (E-mail)
Communicating editor: S. YOKOYAMA
| ABSTRACT |
|---|
The nature of selection on capsid genes of foot-and-mouth disease virus (FMDV) was characterized by examining the ratio of nonsynonymous to synonymous substitutions in 11 data sets of sequences obtained from six different serotypes of FMDV. Using a method of analysis that assigns each codon position to one of a number of estimated values of nonsynonymous to synonymous ratio, significant evidence of positive selection was identified in 5 data sets, operating at 17% of codon positions. Evidence of positive selection was identified in complete capsid sequences of serotypes A and C and in VP1 sequences of serotypes SAT 1 and 2. Sequences of serotype SAT-2 recovered from a persistently infected African buffalo also revealed evidence for positive selection. Locations of codons under positive selection coincide closely with those of antigenic sites previously identified with the use of monoclonal antibody escape mutants. The vast majority of codons are under mild to strong purifying selection. However, these results suggest that arising antigenic variants benefit from a selective advantage in their interaction with the immune system, either during the course of an infection or in transmission to individuals with previous exposure to antigen. Analysis of amino acid usage at sites under positive selection indicates that this selective advantage can be conferred by amino acid substitutions that share physicochemically similar properties.
FOOT-AND-MOUTH disease virus (FMDV) is one of two species in the genus Aphthovirus in the family Picornaviridae and is the causative agent of a highly infectious and economically devastating disease of cloven-hoofed livestock. FMDV is a positive-stranded RNA virus of
8.4 kb that occurs as seven distinct serotypes (A, C, O, Asia 1, and SAT 13), representatives of which are widely distributed throughout South America, Africa, the Middle East, and Asia. FMDV displays considerable antigenic variability in the field (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
FMDV capsids are composed of 60 copies of each of four proteins, VP14, assembled into a nonenveloped icosahedral structure
300 Å in diameter (![]()
![]()
![]()
Monoclonal antibodies (mAbs) have been used to study antigenic sites of many serotypes of FMDV involved in virus neutralization. Epitopes map principally to loops linking ß-strands and that project outward from the virus surface. Independent antigenic sites were identified, involving the three surface-exposed capsid proteins of 01Kaufbeuren strain of FMDV (![]()
![]()
|
In studies of FMDV serotype A, epitopes were also identified on the VP1 GH loop, together with an additional site within the VP1 HI loop (residue 618), adjacent to the BC loop of VP1 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Significant antigenic diversification has been shown to arise even as a result of single point mutations (![]()
![]()
![]()
Due to the immunogenic nature of virus capsids it is inevitable that point mutations to genes encoding the capsid will result in antigenic variation, and this has been repeatedly demonstrated (even in the absence of antibody; ![]()
![]()
![]()
![]()
![]()
Weaknesses of pairwise comparison methods are partly overcome by examining dn/ds ratios over a phylogeny and assigning values of dn/ds to individual codons. Various methods have recently been developed to do this (![]()
![]()
![]()
![]()
![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
The methods of ![]()
![]()
![]()
![]()
![]()
Additional modifications described in ![]()
![]()
![]()
For each data set the phylogenetic trees required for these analyses were constructed using distance methods implemented in the Fitch program of the PHYLIP package (![]()
Physicochemical properties of amino acids at individual codon positions within a data set that were identified as being under positive selection were examined using randomization routines. We asked if average absolute differences in a physical chemical property between c amino acids found at particular sites under positive selection were significantly different from those expected between c randomly selected amino acids. To establish the expected distribution of differences, we examined where the observed average difference occurred in a ranking of average differences of 2000 randomly selected sets of c amino acids. Physical chemical properties were polar requirement, hydrophilicity, molecular weight (![]()
![]()
We applied these methods to 11 different sets of FMDV sequences.
- D1: 28 complete capsid sequences of serotype O;
- D2: 12 complete capsid sequences of serotype A;
- D3: 10 complete capsid sequences of serotype C;
- D4: 43 VP1 sequences of serotype O (a subset of those reported in
HAYDON et al. 1998 );
- D5: 17 VP1 sequences of serotype C (13 from the Philippines and 4 closely related type C's from South America);
- D6: 10 partial VP1 sequences (amino acids 86221) of serotype SAT-1 isolated from South Africa between 19901998;
- D7: 32 partial VP1 sequences (amino acids 85216) of serotype SAT-2 isolated from impala and African buffalo in the Kruger National Park (KNP), South Africa, between 19881996 (
BASTOS et al. 2000 );
- D8: 10 partial VP1 sequences (amino acids 85216) of serotype SAT-2 isolated from a single persistently infected African buffalo over 12 months (
VOSLOO et al. 1996 );
- D9: 12 partial VP1 sequences (amino acids 88217) of serotype SAT-3 isolated from buffalo in the KNP, South Africa, between 19901997;
- D10: 46 partial VP1 sequences (amino acids 157202) of serotype O from isolates from Saudi Arabia between 19831995 (
SAMUEL et al. 1997 );
- D11: 14 partial VP1 sequences (amino acids 157202) of serotype O from isolates from North Africa isolated between 19891991 (
SAMUEL et al. 1999 ).
| RESULTS |
|---|
Evidence for positive selection was found in 5 of 11 data sets (D2, type A capsids; D3, type C capsids; D6, SAT-1 VP1 genes; D7, SAT-2 VP1 genes from impala and buffalo; and D8, SAT-2 VP1 genes from a persistently infected buffalo). Nonsignificant indications of positive selection were found in two further data sets (D5, type C VP1 genes from the Philippines; and D9, SAT-3 VP1 genes). No indication of positive selection was found in data from Saudi Arabia (D10), North Africa (D11), or type O capsids (D1) or VP1 sequences (D4)see Table 1 for estimated parameter values. Where positive selection was indicated, dn/ds ratios were generally <3, the one exception being the persistent SAT-2 virus isolates where a dn/ds ratio of 25 was identified.
|
Sites under positive selection might be identified according to variously stringent criteria. The least stringent is all sites identified as belonging to categories with dn/ds ratios >1 by models that have the greatest likelihood (i.e., most parameters). Using this criterion, of 662 codon positions examined, some evidence for positive selection was identified at 51 different positions in nine different data sets (18 of these sites were coidentified in more than one data set). Of the 51 identified sites, 5 were in ß-strands or
-helices, 41 sites were located in the VP1 gene (16 in the GH loop, 4 in the BC loop, 3 in the EF loop, and 4 in the HI loop); 5 were in VP2 (1 in the BC loop and 2 in the EF loop), and 5 were in VP3 (see Fig 1). Half of the identified sites were located in previously recognized antigenic sitesover seven times a naive random expectation.
The most stringent identification criterion is those sites identified as belonging to categories with dn/ds ratios >1 with posterior probabilities exceeding some threshold (e.g., 0.95), by models with likelihoods significantly greater (at 0.05 level) than the null model. Using this criterion, evidence for positive selection was identified at 17 different positions in five data sets (two of which were coidentified in more than one data set). Of these 17 sites, only 2 were in ß-strands; 15 sites were located on the VP1 gene; and 1 was in each of VP2 and VP3 (see Fig 1). Two-thirds of these sites were located in previously recognized antigenic sitesalmost 10 times a naive random expectation.
The M3(k) models indicated that no data sets justified establishment of more than three different dn/ds categories (four categories were fitted to all data sets and none provided a significant improvement over three). Only the shortest sequences from North Africa and Saudi Arabia were adequately described by a single category, and the remainder required either two or three categories (Table 2). Taken together these analyses suggest that while the vast majority of all codons in all data sets are subject to mild or strong purifying selection, positive selection may act on between 1 and 7% of codons.
|
Examination of 4 physicochemical properties of the different amino acids observed at each of 17 sites involved 17 x 4 = 68 tests so
4 results significant at the 0.05 level were expected by chance alone. In fact, 23 tests proved to be significant at the 0.05 level, all of which suggested physicochemical properties were being conserved at particular sites (see Table 3 for details). Of the 4 physicochemical properties hydrophilicity was conserved at 12 of 17 sites.
|
| DISCUSSION |
|---|
This analysis reveals statistically significant evidence that positive selection can act on between 1 and 7% of codon positions in FMDV capsid genes. The concentration of positively selected sites in loop regions of VP1 is consistent with findings of studies that have used monoclonal antibodies to map epitopes (see Fig 1) and serum immunoglobulin fractionation (![]()
Because the power of this analysis is largely unknown, there is no reason to suppose that all sites on which positive selection might act have been identified. The ability of this test to identify positive selection may depend on the number and relative divergence of the sequences, clarity and structure of phylogenetic signal, and adequacy of the underlying model of nucleotide evolution (in this case the model of ![]()
This general form of analysis has been used previously to identify the action of positive selection in HIV env, gag, pol, vif, and nef genes (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Unrecognized recombination events occurring within a bifurcating phylogeny may lead to an overestimate of the number of substitution events over the tree, but there is no reason to suppose that the estimated overall number of nonsynonymous substitutions will be more biased by this process than the estimated overall number of synonymous substitutions. However, since this analysis has been specifically constructed to identify codon positions with higher dn/ds ratios it appears possible that recombination could potentially lead to some false-positive results, and that this issue requires consideration when recombination rates may be very high. While recombination in FMDV is thought to occur frequently, the short duration of infection and rarity of dual infections suggest that the genetically meaningful recombination rate is likely to be small in most of these data sets. The exception might be the sequences from extended infections of buffalo, where meaningful recombination rates could possibly be higher.
With these cautionary remarks in mind, the identification of positive selection in the SAT-2 sequences from the Kruger National Park (D7) isolated from impala and buffalo is particularly interesting since the phylogeny of these isolates shows repeated interspecific transmission between these two host species (![]()
![]()
![]()
![]()
Finally, this analysis shows that positive selection can result in a pattern of amino acid substitution that is physicochemically conservative. Conservatism may be evident in volume, polarity, hydrophilicity, or molecular weight of amino acids, depending presumably on the exact nature of the structural context of residue positions. However, that the conservation of hydrophilicity appears to be the principal requirement is not unexpected given that these hypervariable amino acid positions are located on the outer capsid surface. This analysis is consistent with that of ![]()
![]()
Positive selection on variants could arise during the course of infection as a result of a specific immune response and be transmitted to immunologically naive individuals. Alternatively, it is possible that the bulk of virus replication and transmission occurs in a short window prior to activation of specific immune responses, and that arising variants are of no selective advantage over the course of a single infection. However, these variants may be endowed with selective advantage at the transmission stage at which point they may be able to infect partially immune individuals with some experience of FMDV antigen, either through previous infection or vaccination. Examination of multiple virus sequences obtained from single individual (nonpersistent) infections could be used to distinguish between these two hypotheses.
| ACKNOWLEDGMENTS |
|---|
We thank Simon Frost, Simon Wain-Hobson, Mark Woolhouse, and Ziheng Yang for many helpful discussions regarding the use of these techniques; two anonymous referees for helpful comments on the manuscript; Susan Lea for providing the structural guide to the O serotype; and David Ansell for technical assistance. D.T.H. is supported by a grant from Wellcome Trust.
Manuscript received June 5, 2000; Accepted for publication September 13, 2000.
| LITERATURE CITED |
|---|
ACHARYA, R., E. FRY, D. STUART, G. FOX, and D. ROWLANDS et al., 1989 The three dimensional structure of foot and mouth disease virus at 2.9 A resolution. Nature 337:709-716[Medline].
BASTOS, A. D. S., C. I. BOSHOFF, D. F. KEET, R. G. BENGIS, and G. R. THOMSON, 2000 Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa. Epidemiol. Infect. 124:591-598[Medline].
BAXT, B., V. VAKHARIA, D. M. MOORE, A. J. FRANKE, and D. O. MORGAN, 1989 Analysis of neutralising antigenic sites on the surface of type A12 foot-and-mouth disease virus. J. Virol. 63:2143-2151
BROWN, F., 1995 Antibody recognition and neutralization of foot and mouth disease virus. Semin. Virol. 6:243-248.
BUSH, R. M., W. M. FITCH, C. A. BENDER, and N. J. COX, 1999a Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 16:1457-1465[Abstract].
BUSH, R. M., C. A. BENDER, K. SUBBARAO, N. J. COX, and W. M. FITCH, 1999b Predicting the evolution of human influenza A. Science 286:1921-1925
BUTCHAIAH, G. and D. O. MORGAN, 1997 Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants. Virus Res. 52:183-194[Medline].
CREIGHTON, T. E., 1983 Proteins: Structures and Molecular Properties. W. H. Freeman, New York.
CROWTHER, J. R., S. FARIAS, W. C. CARPENTER, and A. R. SAMUEL, 1993a Identification of a fifth neutralizable site on type O foot and mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J. Gen. Virol. 74:1547-1553
CROWTHER, J. R., C. A. ROWE, and R. BUTCHER, 1993b Characterization of monoclonal-antibodies against a type SAT-2 foot-and-mouth disease virus. Epidemiol. Infect. 111:391-406[Medline].
CURRY, S., E. FRY, W. BLAKEMORE, R. ABU-GHAZALEH, and T. JACKSON et al., 1996 Perturbations in the surface of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4:135-145[Medline].
DAVIDSON, F. L., J. R. CROWTHER, J. NQINDI, N. J. KNOWLES, and S. J. THEVASAGAYAN et al., 1995 Antigenic analysis of SAT 2 serotype foot-and-mouth disease virus isolates from Zimbabwe using monoclonal antibodies. Epidemiol. Infect. 115:193-205[Medline].
DIEZ, J., M. G. MATEU, and E. DOMINGO, 1989 Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies as revealed by an in situ assay. J. Gen. Virol. 70:3281-3289
DOMINGO, E., and J. J. HOLLAND, 1992 Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents, pp. 1332 in Genetic Engineering, Principles and Methods, Vol. 14, edited by J. K. SETLOW. Plenum Press, New York.
FEIGELSTOCK, D. A., M. G. MATEU, M. E. PICCONE, F. DE SIMONE, and E. BROCCHI et al., 1992 Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside of the major antigenic site. J. Gen. Virol. 73:3307-3311
FEIGELSTOCK, D. A., M. G. MATEU, D. A. VALERO, D. ANDREW, and E. DOMINGO et al., 1996 Emerging foot-and-mouth disease virus variants with antigenically critical amino acid substitutions predicted by model studies using reference viruses. Vaccine 14:97-102[Medline].
FELSENTEIN, J., 1993 PHYLIP (Phylogeny inference package), version 3.5c. Department of Genetics, University of Washington, Seattle.
FITCH, W. M., J. M. E. LEITER, X. LI, and P. PALESE, 1991 Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. USA 88:4270-4274
GOLDMAN, N. and Z. H. YANG, 1994 Codon-based model of nucleotide substitution for protein-coding dna-sequences. Mol. Biol. Evol. 11:725-736[Abstract].
HAYDON, D. T., S. LEA, E. FRY, N. J. KNOWLES, and A. R. SAMUEL et al., 1998 Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype O) with respect to virion structure. J. Mol. Evol. 46:465-475[Medline].
HUGHES, A. L., 1992 Positive selection and interallelic recombination at the Merozoite surface antigen-1 (MSA-1) locus of Plasmodium falciparum.. Mol. Biol. Evol. 9:381-393[Abstract].
HUGHES, A. L., T. OTA, and M. NEI, 1990 Positive Darwinian selection promotes charge profile diversity in the antigen-binding cleft of class 1 major-histocompatibility-complex molecules. Mol. Biol. Evol. 7:515-524[Abstract].
KITSON, J. D. A., D. MCCAHON, and G. J. BELSHAM, 1990 Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26-34[Medline].
LEA, S., J. HERNANDEZ, W. BLAKEMORE, E. BROCCHI, and S. CURRY et al., 1994 The structure and antigenicity of a type C foot and mouth disease virus. Structure 2:123-139[Medline].
MARQUARDT, O., M. M. RAHMAN, and B. FREIBERG, 2000 Genetic and antigenic variance of foot-and-mouth disease virus type Asia1. Arch. Virol. 145:149-157[Medline].
MARTINEZ, M. A., J. HERNANDEZ, M. E. PICCONE, E. L. PALMA, and E. DOMINGO et al., 1991 Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 184:695-706[Medline].
MARTINEZ, M. A., J. DOPAZO, J. HERNANDEZ, M. G. MATEU, and F. SOBRINO et al., 1992 Evolution of capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J. Virol. 66:3557-3565
MATEU, M. G., D. A. SILVA, E. ROCHA, D. L. DE BRUM, and A. ALONSO et al., 1988 Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 167:113-124[Medline].
MATEU, M. G., M. A. MARTINEZ, L. CAPUCCI, D. ANDREW, and E. GIRALT et al., 1990 A single amino acid substitution affects multiple epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-637
MATEU, M. G., J. A. CAMARERO, E. GIRALT, D. ANDREU, and E. DOMINGO, 1995 Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth-disease virus in a natural host. Virology 206:298-306[Medline].
MCCULLOUGH, K. C., F. D. SIMONE, E. BROCCHI, L. CAPUCCI, and J. R. CROWTHER et al., 1992 Protective immune response against foot and mouth disease. J. Virol. 66:1835-1840
NIELSEN, R. and Z. YANG, 1998 Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936
PARRY, N. R., P. V. BARNETT, E. J. OULDRIDGE, D. J. ROWLANDS, and F. BROWN, 1989 Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J. Gen. Virol. 79:1493-1503.
PFAFF, E., H.-J. THIEL, E. BECK, K. STROHMAIER, and H. SCHALLER, 1988 Analysis of neutralizing epitopes on foot and mouth disease virus. J. Gen. Virol. 62:2033-2040.
SALT, J. S., 1993 The carrier state in foot-and-mouth-diseasean immunological review. Br. Vet. J. 149:207-223[Medline].
SALT, J. S., A. R. SAMUEL, and R. P. KITCHING, 1996 Antigenic analysis of type O foot-and-mouth disease virus in the persistently infected bovine. Arch. Virol. 141:1407-1421[Medline].
SAMUEL, A. R., N. J. KNOWLES, R. P. KITCHING, and S. M. HAFEZ, 1997 Molecular analysis of foot-and-mouth disease type O viruses isolated in Saudi Arabia between 1983 and 1995. Epidemiol. Infect. 119:381-389[Medline].
SAMUEL, A. R., N. J. KNOWLES, and D. K. J. MACKAY, 1999 Genetic analysis of type O viruses responsible for epidemics of foot-and-mouth disease in North Africa. Epidemiol. Infect. 122:529-538[Medline].
SEIBERT, S. A., C. Y. HOWELL, M. K. HUGHES, and A. L. HUGHES, 1995 Natural selection on the gag, pol, and env genes of the human immunodeficiency virus (HIV-1). Mol. Biol. Evol. 12:803-813[Abstract].
SHARP, P. M., 1997 In search of molecular Darwinism. Nature 385:111-112[Medline].
STAVE, J. W., J. L. CANE, D. O. MORGAN, and V. N. VAKHARIA, 1988 Neutralisation sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralisation escape variants. Virology 162:21-29[Medline].
SUZUKI, Y. and T. GOJOBORI, 1999 A method for detecting positive selection at single amino acid sites. Mol. Biol. Evol. 16:1315-1328[Abstract].
THOMAS, A. A. M., R. J. WOORTMEIJER, W. PUIJK, and S. J. BARTELING, 1988 Antigenic sites on foot-and-mouth disease virus type A10. J. Virol. 62:2782-2789
VOSLOO, W., A. D. BASTOS, E. KIRKBRIDE, J. J. ESTERHUYSEN, and D. J. VAN RENSBURG et al., 1996 Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth-disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J. Gen.Virol. 77:1457-1467
WOOLHOUSE, M. E. J., D. T. HAYDON, A. PEARSON, and R. P. KITCHING, 1996 Failure of vaccination to prevent outbreaks of foot and mouth disease. Epidemiol. Infect. 116:363-371[Medline].
XIE, Q-C., D. MCCAHON, J. R. CROWTHER, G. L. BELSHAM, and K. C. MCCULLOUGH, 1987 Neutralization of foot and mouth disease virus can be mediated through any of at least three separate antigenic sites. J. Gen. Virol. 68:1637-1647
YANG, Z., R. NIELSEN, N. GOLDMAN, and A.-M. KRABBE PEDERSON, 2000 Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449
ZAMYATNIN, A. A., 1972 Protein volume in solution. Prog. Biophys. Mol. Biol. 24:109-123.
ZANOTTO, P. M., E. G. KALLAS, R. F. SOUZA, and E. C. HOLMES, 1999 Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153:1077-1089
This article has been cited by other articles:
![]() |
D. C. Tully and M. A. Fares Shifts in the Selection-Drift Balance Drive the Evolution and Epidemiology of Foot-and-Mouth Disease Virus J. Virol., January 15, 2009; 83(2): 781 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Heath, E. van der Walt, A. Varsani, and D. P. Martin Recombination Patterns in Aphthoviruses Mirror Those Found in Other Picornaviruses J. Virol., December 1, 2006; 80(23): 11827 - 11832. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Simmonds Recombination and Selection in the Evolution of Picornaviruses and Other Mammalian Positive-Stranded RNA Viruses J. Virol., November 15, 2006; 80(22): 11124 - 11140. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, W. S.W. Wong, and R. Nielsen Bayes Empirical Bayes Inference of Amino Acid Sites Under Positive Selection Mol. Biol. Evol., April 1, 2005; 22(4): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang The power of phylogenetic comparison in revealing protein function PNAS, March 1, 2005; 102(9): 3179 - 3180. [Full Text] [PDF] |
||||
![]() |
R. W. Jobson, R. Nielsen, L. Laakkonen, M. Wikstrom, and V. A. Albert Adaptive evolution of cytochrome c oxidase: Infrastructure for a carnivorous plant radiation PNAS, December 28, 2004; 101(52): 18064 - 18068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Bielawski, K. A. Dunn, G. Sabehi, and O. Beja Darwinian adaptation of proteorhodopsin to different light intensities in the marine environment PNAS, October 12, 2004; 101(41): 14824 - 14829. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Heath, D. P. Martin, L. Warburton, M. Perrin, W. Horsfield, C. Kingsley, E. P. Rybicki, and A.-L. Williamson Evidence of Unique Genotypes of Beak and Feather Disease Virus in Southern Africa J. Virol., September 1, 2004; 78(17): 9277 - 9284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guindon, A. G. Rodrigo, K. A. Dyer, and J. P. Huelsenbeck Modeling the site-specific variation of selection patterns along lineages PNAS, August 31, 2004; 101(35): 12957 - 12962. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Moury Differential Selection of Genes of Cucumber Mosaic Virus Subgroups Mol. Biol. Evol., August 1, 2004; 21(8): 1602 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. d. C. Bronsvoort, A. D. Radford, V. N. Tanya, C. Nfon, R. P. Kitching, and K. L. Morgan Molecular Epidemiology of Foot-and-Mouth Disease Viruses in the Adamawa Province of Cameroon J. Clin. Microbiol., May 1, 2004; 42(5): 2186 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grubman and B. Baxt Foot-and-Mouth Disease Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Grenfell, O. G. Pybus, J. R. Gog, J. L. N. Wood, J. M. Daly, J. A. Mumford, and E. C. Holmes Unifying the Epidemiological and Evolutionary Dynamics of Pathogens Science, January 16, 2004; 303(5656): 327 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Mattioli, A. D. Napoli, V. Ferre, S. Billaudel, R. Perez-Bercoff, and J. Cristina Genetic variability of hepatitis A virus J. Gen. Virol., December 1, 2003; 84(12): 3191 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Woolfit and L. Bromham Increased Rates of Sequence Evolution in Endosymbiotic Bacteria and Fungi with Small Effective Population Sizes Mol. Biol. Evol., September 1, 2003; 20(9): 1545 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anisimova, R. Nielsen, and Z. Yang Effect of Recombination on the Accuracy of the Likelihood Method for Detecting Positive Selection at Amino Acid Sites Genetics, July 1, 2003; 164(3): 1229 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Robles-Sikisaka, K. W. Hasson, D. K. Garcia, K. E. Brovont, K. D. Cleveland, K. R. Klimpel, and A. K. Dhar Genetic variation and immunohistochemical differences among geographic isolates of Taura syndrome virus of penaeid shrimp J. Gen. Virol., December 1, 2002; 83(12): 3123 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Mattioli, J. Cristina, H. Romero, R. Perez-Bercof, D. Casane, R. Colina, L. Garcia, I. Vega, G. Glikman, V. Romanowsky, et al. Molecular Evolution of Hepatitis A Virus: a New Classification Based on the Complete VP1 Protein J. Virol., August 12, 2002; 76(18): 9516 - 9525. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hughes, V. Mioulet, D. T. Haydon, R. P. Kitching, A. I. Donaldson, and M. E. J. Woolhouse Serial passage of foot-and-mouth disease virus in sheep reveals declining levels of viraemia over time J. Gen. Virol., August 1, 2002; 83(8): 1907 - 1914. [Abstract] [Full Text] [PDF] |
||||









